Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center — Houston, Texas

Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Metastatic Adenocarcinoma of the Colon or Rectum, Malignant Solid Tumors.

Sponsors: Baxalta now part of Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

• The University of Texas MD Anderson Cancer Center /ID# 277929
• UT Health/ Memorial Hermann Hospital
• University of Texas Vanguard Urologic Research Foundation
• Anxiety and Health Research Lab, Substance Use Treatment Clinic, University of Houston
• Texas Children's Hospital West Campus
• The Methodist Hospital Houston
• The University Of Texas at Houston
• Houston Methodist Hospital - 6565 Fannin St
• Ben Taub General Hospital / Baylor College of Medicine/Harris Health System
• Lyndon B. Johnson Hospital (Site 1014), 5656 Kelley Street
• The Methodist Hospital Research Institute; Academic Office of Clinical Trials
• University of Texas Health Sciences Center at Houston - Center for Advanced Heart Failure

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center?

Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center conducted?

Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has 1 clinical trials on record. Their work covers Metastatic Adenocarcinoma of the Colon or Rectum, Malignant Solid Tumors.

Is Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center accredited by Crixeo Clinical Trials?

Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.